Podcast: Opportunities for biotechs in precision medicine, driving value and bringing important new therapies to patients

March 4, 2020 PAREXEL

Within the past 20 years, the field of precision medicine has been transformed. For biotech companies, this new landscape holds tremendous promise for innovation. So, why aren’t more companies leveraging this approach? In this episode, Parexel precision medicine experts Angela Qu and Arlene Hughes join host Alberto Grignolo to discuss this conundrum, and what biotechs should be thinking about right from the start, to open up the opportunity for this approach to help bring innovation and new therapies to more patients.  

Previous Article
Episode 7:  International Women’s Day: Insights from Ascending Davos
Episode 7: International Women’s Day: Insights from Ascending Davos

In this episode, Parexel Executive Vice President and Chief Commercial & Strategy Officer Peyton Howell int...

Next Article
Episode 5: CAR-T: How far have we come and where are we going?
Episode 5: CAR-T: How far have we come and where are we going?

In this episode, Doug Olson, one of the first CAR-T patients treated on a clinical trial for CLL almost 10 ...